Bayer (BAYN) Given a €105.00 Price Target at Barclays

Share on StockTwits

Barclays set a €105.00 ($122.09) price objective on Bayer (FRA:BAYN) in a research note issued to investors on Thursday. The brokerage currently has a buy rating on the healthcare company’s stock.

Several other brokerages have also issued reports on BAYN. Sanford C. Bernstein set a €120.00 ($139.53) target price on Bayer and gave the stock a buy rating in a research note on Monday, June 4th. Jefferies Financial Group set a €123.00 ($143.02) target price on Bayer and gave the stock a buy rating in a research note on Monday, June 4th. UBS Group set a €130.00 ($151.16) price objective on Bayer and gave the company a buy rating in a research note on Friday, June 1st. Warburg Research set a €118.00 ($137.21) price objective on Bayer and gave the company a neutral rating in a research note on Monday, June 4th. Finally, Kepler Capital Markets set a €104.00 ($120.93) price objective on Bayer and gave the company a neutral rating in a research note on Monday, June 4th. Nine equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company has an average rating of Buy and an average target price of €104.05 ($120.98).

BAYN traded down €1.83 ($2.13) during midday trading on Thursday, hitting €73.06 ($84.95). The stock had a trading volume of 4,978,109 shares. Bayer has a 1 year low of €91.58 ($106.49) and a 1 year high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

See Also: Average Daily Trade Volume – What It Means In Stock Trading

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply